Holen Sie sich die Stockscreener-App
66.84
2.06%
1.35
Handel nachbörslich:
66.84
Haemonetics Corp Aktie (HAE) Neueste Nachrichten
Is It Time To Reassess Haemonetics (HAE) After The Recent Share Price Jump - simplywall.st
Haemonetics (HAE) Stock Is Up, What You Need To Know - Yahoo Finance
Medical Devices & SuppliesSpecialty Stocks Q1 Highlights: Haemonetics (NYSE:HAE) - Yahoo Finance
Haemonetics (HAE) Upgraded to Buy by Bank of America, Target Pri - GuruFocus
HAE Upgraded by B of A Securities -- Price Target Raised to $80 - GuruFocus
Haemonetics (HAE) Upgraded to Buy by Bank of America, Shares Cli - GuruFocus
Investing in Haemonetics (HAE)? Don't Miss Assessing Its International Revenue Trends - Yahoo! Finance Canada
This Texas Instruments Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday - Benzinga
BofA upgrades Haemonetics stock rating on conservative guidance - Investing.com
HAE Stock Price, Quote & Chart | HAEMONETICS CORP/MASS (NYSE:HAE) - ChartMill
Is It Too Late to Buy Haemonetics Corp (HAE) After 4.0% Rally? G - GuruFocus
Does Haemonetics (HAE) Have Enduring Growth Potential? - Insider Monkey
Q3 2026 Haemonetics Corp Earnings Call Transcript - GuruFocus
Haemonetics Corp 2026 Annual Report: Business Overview, Market Segments, Products, and Competitive Landscape - Minichart
Haemonetics (NYSE: HAE) outlines segment shifts, major customers and risks - Stock Titan
Haemonetics (HAE) EVP and General Counsel receives 28,424 RSUs, 2,913 shares withheld for taxes - Stock Titan
[Form 4] HAEMONETICS CORP Insider Trading Activity - Stock Titan
Haemonetics (NYSE: HAE) CFO granted 29,312 RSUs with tax withholding - Stock Titan
Haemonetics (NYSE: HAE) VP granted 2,220 RSUs, 197 shares withheld for tax - Stock Titan
Haemonetics (HAE) EVP Roy Galvin granted RSUs as 879 shares withheld for taxes - Stock Titan
Haemonetics (HAE) SVP granted RSUs while shares withheld to cover taxes - Stock Titan
Haemonetics (HAE) CEO receives 78,344 RSUs and has shares withheld for taxes - Stock Titan
Does Haemonetics' (HAE) Buyback-Funded Loss Quarter Hint at Shifting Earnings Quality Priorities? - simplywall.st
Haemonetics (HAE) Valuation Check As Earnings Pressure And Options Volatility Raise Questions - simplywall.st
Haemonetics (HAE) Q4 2026 Earnings Transcript - AOL.com
Haemonetics Sees FY27 Revenue, Adjusted EPS Up 4%-7% >HAE - Moomoo
Haemonetics Corp (HAE) Shares Surge 5.5% -- What GF Score of 74 Tells Investors - GuruFocus
North Peak group files 13G/A, Haemonetics (NYSE: HAE) shows ≤5% ownership - Stock Titan
Is the Options Market Predicting a Spike in Haemonetics Stock? - Yahoo Finance
HAE Maintained by Barrington Research -- Price Target Lowered to $89 - GuruFocus
Haemonetics Corp at Bank of America Global Healthcare Conference Transcript - GuruFocus
Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Cuts Target Price to $89 - 富途牛牛
A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness - Yahoo Finance
TradingKey - TradingKey
Why Haemonetics Stock Is Dropping So Sharply - TipRanks
Why Haemonetics (HAE) Is Down 9.5% After Mixed FY26 Results And FY27 Outlook Reset - simplywall.st
Haemonetics Q4 Earnings Call Highlights - sharewise.com
Haemonetics Corporation (NYSE:HAE) Q4 2026 Earnings Call Transcript - Insider Monkey
A Look At Haemonetics (HAE) Valuation After Q4 Loss And Sector-Wide Medical Device Sell Off - simplywall.st
Haemonetics Earnings Call Highlights Growth Amid Headwinds - TipRanks
HAE Maintained by JP Morgan -- Price Target Lowered to $62.00 - GuruFocus
J.P. Morgan Maintains Haemonetics(HAE.US) With Hold Rating, Maintains Target Price $62 - 富途牛牛
Baird Maintains Haemonetics(HAE.US) With Buy Rating, Cuts Target Price to $67 - 富途牛牛
Haemonetics Corporation Q4 2026 Earnings Call Summary - Yahoo Finance
Haemonetics (HAE) Reports Q4 Fiscal 2026 Revenue Growth and Posi - GuruFocus
Needham Maintains Haemonetics(HAE.US) With Hold Rating - 富途牛牛
Haemonetics (HAE) One Off Loss And Margin Hit Challenge Bullish Earnings Narrative - simplywall.st
Earnings call transcript: Haemonetics Q4 2026 beats EPS forecast, stock surges By Investing.com - Investing.com South Africa
Haemonetics Q4 FY2026 slides: earnings beat caps transformation plan - Investing.com
Haemonetics Q4 FY2026 slides: earnings beat caps transformation plan By Investing.com - Investing.com UK
Earnings call transcript: Haemonetics Q4 2026 beats EPS forecast, stock surges - Investing.com Australia
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):